(Statins) and Fixed-dose Combination Products Containing a Statin

Final Report Update 5 Drug Effectiveness Review Project
Acknowledgments
We thank Leah Williams, our publications editor, for putting this report into its present form for
you to read. We also thank Trish Thieda, MA and Miranda Walker, MA for assistance with data
abstraction and quality assessment of studies, and Theresa Nguyen for retrieval of articles and
assistance with editing and formatting.
Suggested citation for this report
Smith MEB, Lee NJ, Haney E, Carson S. Drug class review: HMG-CoA reductase inhibitors
(statins). Update 5.
http://www.ohsu.edu/drugeffectiveness/reports/final.cfm
Funding
The Drug Effectiveness Review Project, composed of 15 organizations including 14 state
Medicaid agencies and the Canadian Agency for Drugs and Technology in Health,
commissioned and funded for this report. These organizations selected the topic of the report and
had input into its Key Questions. The content and conclusions of the report were entirely
determined by the Evidence-based Practice Center researchers. The authors of this report have no
financial interest in any company that makes or distributes the products reviewed in this report.
Statins Page 6 of 128